Multi-Targeted Neurotherapeutic Potential of Cassia alata Linn. Bioactive Phytocompounds: An In Silico Investigational Study
International Journal of Drug Delivery Technology · 02.06.2026 · 16 (44s)
DOI: 10.25258/ijddt.16.44s.49 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Shanmugam V M und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The current outbreak in neurodegenerative disorders in elderly individuals like Alzheimer’s disease (AD), characterized by aggregation and accumulation of amyloid beta (Aβ) due to protein misfolding and improper cleavage and cholinergic deficits mediated by BACE1 (β-secretase) and acetylcholinesterase (AChE). This study utilized Schrodinger suite for molecular docking (Glide XP), 300 ns molecular dynamics simulations (Desomond module) and in silico ADMET profiling to evaluate neuroprotective phytocompounds from Cassia alata Linn. against standard drug Donepezil targeting AChE, BACE1 and Aβ1-42. Donepezil exhibited highest AChE affinity at -9.8 kcal/mol followed by glycidyl palmitate with AChE -8.8 kcal/mol & BACE1 with -7.0 kcal/mol, TBBHP with BACE1 (-6.4 kcal/mol) and linolenoyl chloride with Aβ1-42 (- 6.9 kcal/mol) and C. alata Linn. phytocompounds achieved – 7.1 kcal/mol, showed significant results with the key targets. Desmond MD simulations confirmed stable protein ligand complexes, with BACE1-donepezil RMSD stabilizing at 2.0 – 2.5 Å and persistent hydrogen bonds (Thr232, Gly13). Swiss ADME/ADMET analyses revealed zero to low Lipinski, Ghose and Veber rule violations, high bioavailability (0.55), favourable CNS pharmacokinetics, gastrointestinal absorption, blood brain barrier permeability and absence of PAINS/toxicity alerts complemented by optimal lipophilicity, polar surface area and synthetic accessibility. These findings suggested C. alata Linn. phytocompounds as promising multitarget anti-amyloid aggregative or neuroprotective candidates for AD therapeutics which further demands the experimental validation to prove clinical efficacy.
Zitieren
APA
M, S. V., R, M. K., & B., J. A. (2026). Multi-Targeted Neurotherapeutic Potential of Cassia alata Linn. Bioactive Phytocompounds: An In Silico Investigational Study. International Journal of Drug Delivery Technology, 16(44s). https://doi.org/10.25258/ijddt.16.44s.49
Vancouver
M SV, R MK, B. JA. Multi-Targeted Neurotherapeutic Potential of Cassia alata Linn. Bioactive Phytocompounds: An In Silico Investigational Study. International Journal of Drug Delivery Technology. 2026;16(44s). doi:10.25258/ijddt.16.44s.49
BibTeX
@article{M2026,
author = {M, Shanmugam V and R, Manjula. K. and B., Jolitha A.},
title = {Multi-Targeted Neurotherapeutic Potential of Cassia alata Linn. Bioactive Phytocompounds: An In Silico Investigational Study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {44s},
doi = {10.25258/ijddt.16.44s.49}
}
EUVIMED